StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Quinethazon

Quinethazone

HCID 6307
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
73-49-4
Standard-SMILES
CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1
InChIKey
AGMMTXLNIQSRCG-UHFFFAOYSA-N
Summenformel
C10H12ClN3O3S
Durchschnittliche Molmasse
289,74 g/mol
Monoisotopische Masse
289,0287901

Überblick

Fibrous crystals or white powder. (NTP, 1992)

Namen und Bezeichner

Bevorzugter Name
Quinethazone
IUPAC
7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide
Lokaler Name
Quinethazon
Englischer Name
QUINETHAZONE (1.5 G)
Summenformel
C10H12ClN3O3S
Molmasse
289.73858

Namen und Synonyme

QUINETHAZONE73-49-4HydromoxQuinethazonQuinethazonumAquamoxIdrokinQuinetazona7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamideCL 36010DTXSID90235487-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
Weitere Namen anzeigen
cl36010ChinethazonumQUINETHAZONE (1.5 G)Quinethazone (1594007)
NSC-759904CHEBI:87177-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-sulfamoylquinazoline7-Chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone6-Quinazolinesulfonamide, 7-chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-455E0S048WDTXCID7035487-chloro-2-ethyl-4-hydroxy-1,2-dihydroquinazoline-6-sulfonamide

Datenbank-Bezeichner

CAS
73-49-4
PubChem CID
6307
DTXSID
DTXSID9023548
ChEMBL
CHEMBL1532
ChEBI

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,2
Polarare Oberfläche (TPSA)
110 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
2
Schwere Atome
18
Formalladung
0
Komplexität
436

Experimentelle und physikochemische Eigenschaften

OdorODORLESS
TasteBITTER TASTE
Color/Form · 2 Einträge

Fibrous crystals from 50% acetone

WHITE TO YELLOWISH WHITE, CRYSTALLINE POWDER

Solubility · 5 Einträge

less than 1 mg/mL at 67.1 °F (NTP, 1992)

Sol in acetone, alcohol.

1 G SOL IN 20 ML POLYETHYLENE GLYCOL 300

1 G SOL IN 125 ML PROPYLENE GLYCOL

1 G SOL IN 500 ML ALCOHOL

Human Drugs · 3 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point · 3 Einträge

482 to 486 °F (NTP, 1992)

250-252 °C

251 °C

Physical Description · 2 Einträge

Fibrous crystals or white powder. (NTP, 1992)

Solid

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Gefahrenhinweise

Other Safety InformationIMAP assessments - 6-Quinazolinesulfonamide, 7-chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-: Human health tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 Eintrag

SYMPTOMS: Symptoms of exposure to this compound may include allergies, skin rashes, thirst, epigastric pain, anorexia, gastric irritation, nausea, vomiting, diarrhea, constipation, photosensitivity, dryness, headache, muscle spasm, weakness, inflammation of the salivary gland, loss of libido, paresthesia, acute pancreatitis, pneumonitis, jaundice and other blood disorders. Other symptoms include cramping, hyperglycemia, glycosuria, vertigo, xanthopsia, leukopenia, thrombocytopenia, agranulocytosis, aplastic anemia, purpura, urticaria, necrotizing angiitis and restlessness.

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Reactive GroupAmides and Imides
Air and Water ReactionsInsoluble in water.

Sicherheit und Schutzausrüstung

Fire FightingFires involving this chemical may be controlled with a carbon dioxide, dry chemical or Halon extinguisher. (NTP, 1992)
First Aid · 1 Eintrag

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

C - Cardiovascular system

QC - Cardiovascular system

Pharmacodynamics · 1 Eintrag

Quinethazone is a thiazide diuretic used to treat hypertension. It inhibits Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Mechanism of Action · 6 Einträge

As a diuretic, quinethazone inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like quinethazone also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of quinethazone is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

...BENZOTHIADIAZIDES HAVE DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE INDEPENDENT OF CARBONIC ANHYDRASE INACTIVATION. ...HAVE PARALLEL DOSE-RESPONSE CURVES & COMPARABLE MAX CHLORURETIC EFFECTS. /BENZOTHIADIAZIDES/

RENAL ACTIONS OF THIAZIDE DIURETICS DECR EXTRACELLULAR FLUID & PLASMA VOL, CARDIAC OUTPUT, & TOTAL EXCHANGEABLE SODIUM IN INDIVIDUALS WITHOUT ANY EVIDENCE OF CARDIAC FAILURE. ...SODIUM & WATER DEPLETION...BASIS FOR ANTIHYPERTENSIVE EFFECT. ...DIURETIC THIAZIDES RELAX PERIPHERAL ARTERIOLAR SMOOTH MUSCLE. /BENZOTHIADIAZIDES/

Decreased plasma volume and decreased extracellular fluid volume; decreased cardiac output initially, followed by decreased total peripheral resistance with normalization of cardiac output ... /from table/

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CHEBI:8717
UNII
455E0S048W
EC Number
200-801-7
Nikkaji
J1.429J
Stability/Shelf Life
DISCOLORS IN PRESENCE OF STRONG LIGHT & ALKALINE MATERIALS
Other Experimental PropertiesIT DIFFERS CHEMICALLY FROM THE BENZOTHIAZIDE TYPE ONLY IN REPLACEMENT OF SULFUR ATOM BY CARBON

Physikochemische Eigenschaften

Schmelzpunkt
250 · 250-252°
Dichte
1.4208 · 1.4208 (rough estimate)
Brechungsindex
1.63 · 1.6300 (estimate)
storage temp.
Refrigerator
Löslichkeit
DMSO (Slightly), Methanol (Slightly, Sonicated)
Aggregatzustand
Solid
pka
9.3 · pKa 9.3 (Uncertain);10.7 (Uncertain)
Farbe
Pale Beige to Brown
Wasserlöslichkeit
0.15 g/L · 0.15g/L(25 ºC)
Stabilität
Stable. Combustible. Incompatible with strong oxidizing agents.
EPA chemische Informationen
Quinethazone (73-49-4)

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: If you spill this chemical, dampen the solid spill material with 5% ammonium hydroxide, then transfer the dampened material to a suitable container. Use absorbent paper dampened with 5% ammonium hydroxide to pick up any remaining material. Your contaminated clothing and the absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with 5% ammonium hydroxide followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Personal Protective Equipment (PPE) · 1 Eintrag

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxikologische Informationen

Interactions · 5 Einträge

MANY DIABETIC PT REGULATED BY CHLORPROPAMIDE OR OTHER SULFONYLUREAS EXHIBIT IMPAIRED DIABETIC CONTROL WHEN ANY THIAZIDE DIURETIC IS ADDED TO DRUG REGIMEN. /QUINETHAZONE/...SHOULD BE EXPECTED TO INTERACT IN A SIMILAR MANNER.

PT RECEIVING /THIAZIDES & RELATED DIURETICS/...MAY DEVELOP ELECTROLYTE DISTURBANCES...WHICH MAY ENHANCE CARDIOTOXICITY OF DIGITALIS. /QUINETHAZONE/...CAN CAUSE HYPOKALEMIA, & MAY BE EXPECTED TO INTERACT WITH CARDIAC GLYCOSIDES.

THIAZIDES ENHANCE ANTIHYPERTENSIVE ACTION OF GUANETHIDINE... /QUINETHAZONE/...SHOULD BE EXPECTED TO INTERACT WITH GUANETHIDINE ALSO.

/QUINETHAZONE/...MAY ENHANCE NEUROMUSCULAR BLOCKADE PRODUCED BY TUBOCURARINE...

For more Interactions (Complete) data for QUINETHAZONE (20 total), please visit the HSDB record page.

Human Toxicity ExcerptsCLINICAL TOXICITY...USUALLY RESULTS FROM UNEXPECTED HYPERSENSITIVITY. CASES HAVE BEEN REPORTED WITH PURPURA, DERMATITIS WITH PHOTOSENSITIVITY, DEPRESSION OF FORMED ELEMENTS OF BLOOD, & NECROTIZING VASCULITIS. /BENZOTHIADIAZIDES/
Antidote and Emergency TreatmentThiazide diuretic overdose should be treated by ... supportive symptomatic treatment and monitoring of serum electrolyte concentrations and renal function. /Thiazide diuretic/

Regulatorische Informationen

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Sicherheitsdaten

Giftige Stoffe Daten
73-49-4(Hazardous Substances Data)

Thiazide diuretics increase urinary excretion of sodium and water by inhibiting sodium reabsorption in the early distal tubules. They increase the rate of delivery of tubular fluid and electrolytes to the distal sites of hydrogen and potassium ion secretion, while plasma volume contraction increases aldosterone production. The increased delivery and increase in aldosterone levels promote sodium reabsorption at the distal tubules, thus increasing the loss of potassium and hydrogen ions. /Thiazide diuretics/

For more Mechanism of Action (Complete) data for QUINETHAZONE (7 total), please visit the HSDB record page.

MeSH Pharmacological ClassificationAgents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.
Absorption, Distribution and Excretion...RAPIDLY ABSORBED FROM GI TRACT...
Cellular LocationsCytoplasm
Metabolite PathwaysQuinethazone Action Pathway

Verwendung und Herstellung

Uses · 2 Einträge

Therap cat: Diuretic, Antihypertensive

...an orally effective benzothiadiazine diuretic and antihypertensive drug.

Methods of Manufacturing · 2 Einträge

Cohen et al, J Am Chem Soc 82, 2731 (1960); Cohen, Vaughan, Jr, US patent 2,976,289 (1961 to Am Cyanamid).

4'-CHLORO-O-ACETOTOLUIDIDE IS SUBJECTED TO CHLOROSULFONATION & SUBSEQUENT AMINATION TO FORM 2-AMINO-4-CHLORO-5-SULFAMOYLBENZAMIDE. REFLUXING WITH AN ACIDULATED ALCOHOLIC SOLUTION OF THE DIETHYLACETAL OF PROPIONALDEHYDE EFFECTS THE REQUIRED CONDENSATION CYCLIZATION TO YIELD QUINETHAZONE.

Use ClassificationPharmaceuticals

Anwendungen

VerwendenQuinethazone is a thiazide diuretic used to treat hypertension.